LTR Pharma (Australia) Performance
| LTP Stock | 0.49 0.02 3.92% |
The company secures a Beta (Market Risk) of 0.67, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, LTR Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding LTR Pharma is expected to be smaller as well. LTR Pharma presently secures a risk of 5.0%. Please verify LTR Pharma total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to decide if LTR Pharma will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days LTR Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, LTR Pharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
1 | LTR Pharma to Release Securities from ASX Escrow, Enhancing Market Liquidity - TipRanks | 12/01/2025 |
2 | LTR Pharma Receives TGA Clearance for SPONTAN Phase II Study - TipRanks | 12/09/2025 |
3 | LTR Pharma Doses First Patient in Phase Two Study of Spontan Shares Up 4 percent - | 01/21/2026 |
| Begin Period Cash Flow | 1.7 M | |
| Total Cashflows From Investing Activities | -1980.00 | |
| Free Cash Flow | -5.1 M |
LTR |
LTR Pharma Relative Risk vs. Return Landscape
If you would invest 52.00 in LTR Pharma on November 11, 2025 and sell it today you would lose (3.00) from holding LTR Pharma or give up 5.77% of portfolio value over 90 days. LTR Pharma is generating 0.0205% of daily returns assuming 5.0014% volatility of returns over the 90 days investment horizon. Simply put, 44% of all stocks have less volatile historical return distribution than LTR Pharma, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
LTR Pharma Target Price Odds to finish over Current Price
The tendency of LTR Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.49 | 90 days | 0.49 | about 69.9 |
Based on a normal probability distribution, the odds of LTR Pharma to move above the current price in 90 days from now is about 69.9 (This LTR Pharma probability density function shows the probability of LTR Stock to fall within a particular range of prices over 90 days) .
LTR Pharma Price Density |
| Price |
Predictive Modules for LTR Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LTR Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.LTR Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. LTR Pharma is not an exception. The market had few large corrections towards the LTR Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LTR Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LTR Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.09 | |
β | Beta against Dow Jones | 0.67 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | 0.01 |
LTR Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LTR Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LTR Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| LTR Pharma had very high historical volatility over the last 90 days | |
| LTR Pharma has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.1 M. Net Loss for the year was (6.95 M) with loss before overhead, payroll, taxes, and interest of (1.28 M). | |
| LTR Pharma generates negative cash flow from operations | |
| About 42.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: LTR Pharma Doses First Patient in Phase Two Study of Spontan Shares Up 4 percent - |
LTR Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LTR Stock often depends not only on the future outlook of the current and potential LTR Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LTR Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 181 M | |
| Cash And Short Term Investments | 31.8 M |
LTR Pharma Fundamentals Growth
LTR Stock prices reflect investors' perceptions of the future prospects and financial health of LTR Pharma, and LTR Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LTR Stock performance.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (3.51) % | ||||
| Current Valuation | 57.24 M | ||||
| Shares Outstanding | 181.73 M | ||||
| Price To Book | 2.83 X | ||||
| Price To Sales | 59.03 X | ||||
| Revenue | 2.1 M | ||||
| EBITDA | (6.1 M) | ||||
| Net Income | (6.95 M) | ||||
| Total Debt | 700.57 K | ||||
| Book Value Per Share | 0.17 X | ||||
| Cash Flow From Operations | (5.09 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Total Asset | 32.21 M | ||||
| Retained Earnings | (12.69 M) | ||||
About LTR Pharma Performance
Assessing LTR Pharma's fundamental ratios provides investors with valuable insights into LTR Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the LTR Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
LTR Pharma is entity of Australia. It is traded as Stock on AU exchange.Things to note about LTR Pharma performance evaluation
Checking the ongoing alerts about LTR Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LTR Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LTR Pharma had very high historical volatility over the last 90 days | |
| LTR Pharma has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.1 M. Net Loss for the year was (6.95 M) with loss before overhead, payroll, taxes, and interest of (1.28 M). | |
| LTR Pharma generates negative cash flow from operations | |
| About 42.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: LTR Pharma Doses First Patient in Phase Two Study of Spontan Shares Up 4 percent - |
- Analyzing LTR Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LTR Pharma's stock is overvalued or undervalued compared to its peers.
- Examining LTR Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LTR Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LTR Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LTR Pharma's stock. These opinions can provide insight into LTR Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for LTR Stock Analysis
When running LTR Pharma's price analysis, check to measure LTR Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LTR Pharma is operating at the current time. Most of LTR Pharma's value examination focuses on studying past and present price action to predict the probability of LTR Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LTR Pharma's price. Additionally, you may evaluate how the addition of LTR Pharma to your portfolios can decrease your overall portfolio volatility.